TP53 and cancer: Inspection of the MSigDB for cancer relevant gene sets, C6.Oncogenic signatures and C4.Cancer modules, enriched among the 577 genes with increased 5hmC densities revealed a preponderance of gene sets that are upregulated in both KRAS and TP53 mutant cancers (Fig. 3c).